Skip to main content

and
  1. No Access

    Article

    Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)

    Glioblastoma multiforme (GBM) is a nearly uniformly fatal brain tumor with a median recurrence rate of 7 months and survival of 14 months after multimodality treatment. We sought to evaluate outcomes based on ...

    Arya Amini, Basel Altoos, Sana D. Karam in Journal of Radiation Oncology (2016)